510(k) K211302
K211302 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Syphilis". The FDA issued a decision of Substantially Equivalent on July 20, 2021. The device falls under product code LIP (Enzyme Linked Immunoabsorption Assay, Treponema Pallidum), a Class II device regulated under 21 CFR 866.3830. Roche Diagnostics has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 20, 2021
- Date Received
- April 29, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Linked Immunoabsorption Assay, Treponema Pallidum
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type